View all veterinary jobs
The maker, MSD Animal Health, says Numelvi is "the first and only “second-generation” Janus kinase (JAK) inhibitor indicated from six months of age (and 3kg) for the treatment of pruritus associated with allergic dermatitis, including atopic dermatitis, as well as the clinical manifestations of atopic dermatitis in dogs. .
It is given once daily and MSD says it is clinically effective after the first dose.
The company says itch relief begins within 2–4 hours and dosing is one tablet a day from day one.
MSD claims Numelvi is at least 10 times more selective for JAK1 compared with other JAK family members (JAK2, JAK3 and TYK2).
Numelvi can be used concurrently with vaccines (including rabies) and other common treatments such as ectoparasiticides, with no requirement for routine blood and urine monitoring.
Dermatology specialist Dr Debbie Gow said: “Second-generation JAK inhibitors are selective — specifically, in this case, more selective for JAK1 than other JAK enzymes.
“The high selectivity for JAK 1 contributes to the favourable safety profile of Numelvi.”
Dr Sue Paterson MA VetMB DVD DipECVD FRCVS added: “Treating canine allergic dermatitis means offering treatment which relieves itch and inflammation, whilst managing any unwanted side effects.
"We want to inhibit JAK 1 to reduce itch and inflammation, whilst having little to no effect on other JAK family members.”
MSD Animal Health will host a lunch-and-learn digital launch event with The Webinar Vet on Thursday 26 March, aiming to set a Guinness World Record for a veterinary educational launch event.
That'll bring the GB list price down from £434 to £347.20, something which can only be good news at a time when the veterinary profession is facing greater scrutiny over the cost of care than ever before.
The company says it will also be increasing the product discount, which can be discussed with its Account Managers.
MSD says the price drop makes Bravecto Injectable the most affordable way to protect dogs with Fluralaner and highlights the convenience of annual dosing and the fact that it avoids tricky discussions about where to buy the product.
https://www.msd-animal-health.co.uk/
Bravecto Triuno is approved for the treatment of tick and flea infestations in dogs (Ctenocephalides felis, C. canis, Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus, and Rhipicephalus sanguineus).
It is also approved for the treatment of infections with roundworms (adult stages of Toxocara canis and Toxascaris leonina) and hookworms (L4, immature adult (L5), and adult stages of Ancylostoma caninum and Uncinaria stenocephala), for the prevention of heartworm disease (caused by Dirofilaria immitis), and for the prevention of angiostrongylosis (by reduction of the level of infection with immature adult (L5) and adult stages of Angiostrongylus vasorum).
Victoria Miles, UK Companion Animal Director, MSD Animal Health, said: “With this latest formulation of Bravecto, MSD Animal Health is giving veterinarians and dog owners a greater range of convenient options for protecting their dog year-round from parasites, and all from the same trusted Bravecto portfolio.”
She added: “We see Bravecto Triuno as a great option for puppies that require a monthly wormer on top of protection against fleas and ticks.
"This also gives flexibility later on for the dog to remain with the Bravecto brand but be swapped onto a longer-duration flea and tick product with a wormer administered according to a veterinarian’s risk-based assessment.”
Bravecto Triuno is available as a flavoured chewable tablet indicated for dogs and puppies from 8 weeks of age and at least 1.27 Kg body weight and can be administered monthly to dogs at risk of infestation by multiple types of internal and external parasites.
It contains three anti-parasitic ingredients including fluralaner, which provides activity against ticks and fleas, moxidectin, which provides systemic activity against non-intestinal worms, and pyrantel, which provides activity against intestinal worms.
https://www.noahcompendium.co.uk/?id=-488423
This new injectable fluralaner formulation is approved for the immediate and persistent killing of fleas for one year (Ctenocephalides felis and Ctenocephalides canis), from 3 days to 12 months after treatment for the ticks Ixodes ricinus, and Dermacentor reticulatus, from 4 days to 12 months after treatment for Rhipicephalus sanguineus, and from 7 days to 12 months after treatment for Ixodes hexagonus.
MSD says it will also reduce the risk of Babesia canis via transmission by Dermacentor reticulatus from day 3 after treatment for up to 12 months, and also reduces the risk of infection with Dipylidium caninum via transmission by Ctenocephalides felis for up to 12 months.
Victoria Miles, UK Companion Animal Business Unit Director, MSD Animal Health said: “Imagine not having to worry about flea and tick protection for a whole year.
Bravecto 150 mg/ml powder and solvent for suspension for injection for dogs can be administered to dogs and puppies six months of age and older.
The product is already available in France and Germany and MSD told VetNurse.co.uk that stocks are expected in the UK in September, for which the company is now taking pre-orders.
Contact your MSD Account Manager for further information on pricing.
MSD says the new chip is compliant with ISO standards, has proven temperature accuracy1 and as yet is the only microchip on the market that combines identification and temperature monitoring.
The HomeAgain Thermochip has been designed to work for the lifetime of the pet, and it's being launched alongside the HomeAgain Pet Recovery Database, which is free of charge.
Michael Morrow BSc BVSc MRCVS, Director of St Vincents Veterinary Surgery in Wokingham, has been involved in trials of the new chip. He said: ''The launch of HomeAgain Thermochip is a real game-changer in the market.
“We have been trialling the Thermochip for some time and it’s now our default option to measure temperature.
"It’s incredibly useful in everyday practice, particularly when it comes to fractious cats or extremely nervous dogs, and it improves efficiency in consultations.
"We also use the Thermochip extensively during anaesthetic and post operative monitoring – with minimal handling.
“Reassuringly, we’ve never had any issues with the microchip reader or with the chip migrating to other parts of an animal’s body so it’s very reliable.”
In addition to the benefit of being able to measure temperature in a non-invasive way, MSD points to recent studies which suggest that a pet’s ‘normal’ temperature is not a specific number, rather a range of values that depend on numerous factors such as the time of day, the site of measurement, sex, breed, size, age, activity and stress levels2.
The HomeAgain Thermochip makes it easier to take multiple temperature readings easily over time, thereby establishing a pet’s individual temperature range.
For animal identification, the microchip works in much the same way as other microchips.
Once the owner registers their pet’s microchip with a recovery database, their animal – in theory – can be traced if lost.
The reality is often different, because owners' contact details are frequently out of date, making it difficult to reunite pets.
MSD says it aims to have the most comprehensive reunification platform, with a database which:
For more information, visit: homeagain.co.uk
Reference
The company says that with an estimated 3.2 million UK households welcoming a new pet into their family home during lockdown1, many experienced and new dog owners will be unaware of the risks to their dog of CCC when it socialises, hence the new risk assessment tool, which is available at: https://www.msd-animal-health-hub.co.uk/KBPH/contagious-canine-cough-risk-assessment.
The risk assessment campaign will be supported with 'Does your dog ...' posters for vets, information and advice for dog owners on the website and a social media campaign encouraging dog owners to spread the information to other dog owners.
Carley Chutter, Nobivac(r) Product Manager at MSD Animal Health said: "With so many new dog owners now socialising more, taking their dogs on holiday and even considering taking their dogs into the office, protecting their dogs as they socialise is vital.
"Currently only an estimated 1 in 3 vaccinated dogs in the UK are also covered against Bordetella2 so the 'Ask us to protect your dog' resources offers the chance for practices to start the conversation about protection with clients.
"A common barrier to vaccinating against CCC is the belief that it is only necessary for dogs going into kennels, rather than all social dogs. Most dogs meet others, however, while out walking, during training, or while attending the vets, CCC is infectious even at low levels. Indeed, dogs can be asymptomatic but infectious.
"So, improving protection levels against this disease which is distressing for both the owner and dog, is important in both reducing the risk of outbreaks and the need for antibiotic treatment."
Nobivac(r) Respira Bb injectable vaccine against Bordetella bronchiseptica, gives 12 months protection when used as a single-dose booster in dogs previously vaccinated with Nobivac(r) KC. Dogs not previously vaccinated against Bordetella bronchiseptica require two doses administered four weeks apart. Duration of immunity is 7 months after the primary course and 12 months after a booster with Nobivac(r) Respira Bb. It may also be given 12 months after a primary course in cases where the 7 months dose is missed.
To support the use of Nobivac(r) Respira Bb a range of tools are available to practices and further information can be found at www.nobivacrespiraBb.co.uk, or contact your MSD Animal Health account manager.
References
MSD says the Summer Staycation campaign is designed to support the needs of new dog owners and those taking their dogs to areas outside their local region, where parasites risks will be different.
The campaign offers veterinary practices a range of resources, including client emails, a downloadable guide to parasites, social media posts and an interactive risk checker on the Keeping Britain's Pets Healthy website. There is also some training for front of house staff and receptionists at https://www.msd-animal-health-hub.co.uk/cpd/staycation.
Nicola Barclay, Senior Product Manager at MSD Animal Health said: "Summer holidays will be taking a different form this year with most people planning trips in the UK, making it more likely they will take their pets.
"What's important is that seasoned and new owners alike are aware of the parasite risks in the places they're visiting so they aren't putting the health of their pets at risk.
"We're therefore providing a range of resources to help veterinary practices encourage pet owners to make sure there are no breaks in their parasite protection and vaccinations and that they are appropriately protected for the places they'll be visiting."
Dr Ian Wright, Head of ESCCAP UK & Ireland added: "The research findings from The Big Tick Project in 2015 found that 1 in 3 dogs coming into veterinary practices during the summer months had ticks on them.
"Research is also showing many parasites extending their range with an increased risk of human and pet exposure. Warming temperatures mean that ticks can be encountered all year round in the UK, carrying potentially dangerous pathogens to dogs and people including Lyme disease and Tick-borne encephalitis virus (TBEV).
"With so many new dog owners and people being more likely to holiday in the UK, making sure dog owners understand the risks, while keeping them in proportion, and giving appropriate protection advice is vital.''
For more information, contact your MSD Animal Health account manager.
The company hired Onswitch to call 700 veterinary practices and ask about kennel cough. 43% of callers were told it was up to them whether their dog had a vaccine for CIRD, with no clear recommendation in over 50% of calls.
MSD says that there was very little detailed information given about CIRD or kennel cough or vaccinations, with nothing at all mentioned in 18% of calls.
Whilst 18% of calls mentioned that dogs can contract kennel cough mixing with other dogs, 9% were told that their dog would only need the vaccination if it was going into kennels!
According to the company, vaccination for Bordetella bronchiseptica and canine parainfluenza virus has declined dramatically during lockdown, with over 350,000 less doses being bought in 2020 vs 2019 April - December1, however the risks are still prevalent, because dogs are still mixing.
Michelle Townley, Veterinary Advisor for the Companion Animal team at MSD Animal Health said: "CIRD, more commonly known as kennel cough, is often mistakenly believed to be only a disease of kennels. The reality is that respiratory pathogens are most commonly transmitted between dogs that mix or share the same air space. This results in risk anywhere where dogs are being social, including parks, groomers and vet practices. Due to this confusion, we recommend referring to the disease with pet owners as contagious canine cough."
She added: "This data reveals a significant amount of confusion in the advice veterinary practices give to dog owners in relation to protection against CIRD,or contagious canine cough. Practice team members have often received no formal training on what to tell dog owners and how to discuss CIRD, so messages vary widely and are not always correct. This data reveals that there is a great opportunity for practices to proactively discuss contagious canine cough as a standard component of the annual vaccination programme and ensure more dogs that socialise with other dogs and are at risk get the protection they need."
For more information on the Nobivac vaccine range, vaccine protocols and product and team training, contact your MSD Account Manager or visit www.nobivacrespirabb.co.uk.
The new vaccine offers 12 months protection when used as a single-dose booster in dogs previously vaccinated with Nobivac(r) KC. It is presented in a 10ml multi-dose vial which can be stored in or out of a refrigerator for 28 days after broaching.
Dogs not previously vaccinated against Bordetella bronchiseptica need two doses administered four weeks apart.
The duration of immunity is 7 months after the primary course and 12 months after a booster with Nobivac(r) Respira Bb. It can also be given 12 months after a primary course in cases where the 7 month dose is missed.
Blaise Scott-Morris, Product Manager, MSD Animal Health said: "Currently only an estimated 1 in 3 vaccinated dogs in the UK are also covered against Bordetella1 so Nobivac(r) Respira Bb offers the chance for practices to re-start the conversation about protection with clients.
"A common barrier to Canine Infectious Respiratory Disease (CIRD) protection, caused by Bordetella, is the belief that it is only necessary for dogs going into kennels, rather than all social dogs. Most dogs meet others however, while out walking, during training, or while attending the vets, and CIRD is infectious even at low levels. Indeed, dogs can be asymptomatic but infectious.
According to the company, trials showed that dogs vaccinated with Nobivac(r) Respira Bb demonstrated a significant reduction in clinical signs of respiratory disease and a reduction in bacterial shedding2. It has also been safely demonstrated in a wide range of breeds3 and has proven efficacy in puppies challenged two weeks after the primary course of vaccination4. It can be given concurrently with many other Nobivac(r) vaccines.
MSD says the new vaccine is most suitable for dogs:
Further information can be found at www.nobivacrespiraBb.co.uk, or contact your MSD Animal Health account manager.
References:
The company announced last month that from 1st January next year, practices will have to order companion animal and ruminant products via either MWI or NVS (who will also fulfil the order), but will be invoiced direct by MSD.
Pig products will join aquaculture and poultry products to be supplied directly to customers by MSD Animal Health.
In its announcement, the company said that the new structure would allow the company to enhance the customer experience and more quickly adapt to changes in the market to better serve its customers.
VetNurse.co.uk contacted the company for further clarification about how the customer experience would be improved.
The company explained that the two main benefits of the new structure concern price visibility and stock control.
A spokesperson for the company said: "Currently, customers may get a discount from us and separately a discount from wholesaler. With our new distribution model we will invoice monthly and all discounts will be on one invoice, so it will be easier to determine the actual price paid."
The spokesperson explained that with the old model, once stock was sold to wholesalers it would be allocated to customers, so there would be some held by MSD, some allocated and some in distribution: "The benefit of the new model is we will have full oversight of stock as it will be in our own warehouses or with distribution partners. If there are disruptions in the market, we will have better awareness of in market demand and we can allocate stock appropriately".
Amanda Melvin, Marketing Manager for the Companion Animal Team at MSD Animal Health said: "Research has shown that up to 20% of diabetic pets die, or are euthanised, within a year of diagnosis1 so we want to do everything we can to prevent any further increases in this figure.
"Recent circumstances have put most practices under a great deal of strain and it's become clear from the increase in calls we're receiving that there is a high demand for more information and resources to support the care of diabetic pets.
"We've therefore decided that with Pet Diabetes Month in November, our best way of supporting veterinary practices is to make them aware of, and know how to access the resources we have available to help them."
The diabetes resources include veterinary nurse clinics and training, getting the most out ofVetPen, monitoring support tools and case advice.
Veterinary professionals can subscribe for access to the materials as individuals or as a practice team.
For further information, visit https://www.msd-animal-health-hub.co.uk/ahp/caninsulin/tools.
Katie won the trophy for her research and presentation on quantifying and monitoring practice cleanliness.
The runner up, who won £500, was Glasgow University veterinary student, Alysia Empert-Gallegos for her research into owner perspectives on feeding raw diets to dogs.
Katie, who is Deputy Head Veterinary Nurse at Chipping Norton Veterinary Hospital, said: "I am very grateful to MSD Animal Health for awarding me the research bursary and prize.
"Cleanliness is such an important subject area for the veterinary field and I'm pleased that I can hopefully inspire others to monitor it effectively; enabling us to continually improve our standards across the industry.
"I am excited to be the first Veterinary Nurse to take part and win, and hope that I can encourage other nurses to take an interest in research and help improve standards."
Michelle Townley, Veterinary Advisor at MSD Animal Health, said: "It was wonderful that this year everyone could present, no matter where they are working in the world, and despite the event having to be virtual this year, there was a huge amount of energy in the 'room', that shone through from the enthusiasm of the presenters. Their love of their work and commitment to research was apparent to everyone on the judging panel. It was a great day all round and we're excited and delighted to have awarded the top prize to our first veterinary nurse and Katie's extremely valuable and practical work on monitoring clinical hygiene."
Photo: Katie Whalley with Michelle Townley
Susan Little, pictured left, talks about ‘Low Stress Management of the Diabetic Cat’, Professor Ian Ramsey gives his: ‘Top Ten Tips on Diabetes on a Budget’, and Grant Petrie presents: ‘Patients in Lockdown’: principles to manage diabetes remotely.
John Helps, Senior Veterinary Advisor at MSD Animal Health said: “Pet diabetes continues to be of increasing importance in the UK. Research has shown that up to 20% of diabetic pets die, or are euthanised, within a year of diagnosis1. No-one wants to these figures rise further because of the recent challenges so the topics covered are all particularly relevant to veterinary practice teams at this time.”
To watch the presentation, use this memorable link: https://onlinexperiences.com/Launch/QReg/ShowUUID=ADB18692-C804-40FD-B8C3-5D97C7DBC333&LangLocaleID=1033.
Further information for veterinary professionals from: https://www.msd-animal-health-hub.co.uk/ahp/caninsulin/tools.
For pet owners, the Caninsulin website offers more information about diabetes: www.caninsulin.co.uk.
To use the service, practices have to register for VetsDeliver via Easy Direct Debit (which handles payments), then configure the system for the number of consultation rooms needed and to add practice branding. The first consultation room costs £69 per month, with discounts for subsequent rooms.
Practices can promote the service to pet owners by sharing a link for appointments via social media, the practice website, or a mail out to clients.
Clients then follow the shared link, complete a form and book a consultation slot.
After the consultation, the practice can email a link to the pet owner so that they can pay for any medication.
Adrian Tantrum (that must have been quite a cross to bear at school), Head of the Companion Animal Business Unit at MSD Animal Health said: "As market leaders, with brands such as Bravecto, Nobivac and Caninsulin, we want to help practices adapt to the new normal.
"We have listened to feedback from practices around what they want from a telemedicine platform and worked with EDD to create a simple and easy to use service. This will allow practices to provide pet owners with the support they need, whether it be their parasiticide prescriptions or providing continuity of care for diabetic patients, and will of course bring much-needed cash flow into their practices.
"We've chosen Zoom for the video capabilities as it is one of the most popular video conference apps with millions of users worldwide, so we know it's familiar to most pet owners."
Adrian added: "As we all adjust to new ways of working we are putting in place a whole series of new services for practices that will help bring them closer to their clients and allow them to continue to provide pet owners with the expertise and support they need. Being able to see a vet 'face-to-face', if not in the flesh, will be reassuring for a lot of pet owners who will be worrying about both new and on-going conditions."
For more information, contact your MSD account manager.
A single 0.5ml vaccination provides 12 months immunity against all three pathogens, which will make vaccination more convenient and should help improve levels of compliance against variant strains of RHD which is currently estimated to be at around only 60% of the vaccinated rabbit population.
Nobivac Myxo-RHD Plus is available in a pack of five, single dose vials, with a shelf-life of two years. The vaccine can be used from the age of five or seven weeks onwards to achieve the full duration of immunity. Immunity is provided within three weeks of administration.
Leonora Bell, Product Manager at MSD Animal Health said: "It's clear that this year the usually busy spring season, where purchasing and vaccinating rabbits is at its highest, will not be as predictable as previous years. Vaccinating rabbits is unlikely to be at the top of your agenda. MSD Animal Health's new Nobivac Myxo-RHD PLUS has arrived, however, so this is a good opportunity to understand how to safely switch vaccinated rabbits and introduce new rabbits to vaccination. This is a time when clients can be encouraged back into your practice, ideally prior to the increase in infectious disease which we tend to see during the peak summer months.
"The variant RHD-2 strain appears now to predominate in cases of rabbit haemorrhagic disease and readily transfers over long distances via flies and the wind. Vaccinating rabbits that live both outdoors and indoors is therefore vital. Rabbits are popular pets and rabbit owners are highly motivated to seek veterinary advice once they are made aware of their pet's specific health needs. They are, however, much less likely to take their pet to a veterinary practice than cat or dog owners or to seek advice on vaccination, neutering or other routine health matters."
Leonora added: "Production of our existing Nobivac Myxo-RHD vaccine will necessarily be replaced with the new Nobivac Myxo-RHD PLUS to ensure that rabbits are vaccinated in the most appropriate way. Following the correct switching protocol is therefore vital. For unvaccinated rabbits it's a simple case of starting with the new vaccine. For rabbits due for a booster of Myxomatosis, RHD1 and RHD2, again, vets can simply switch to the new vaccine when the booster is normally due. Where rabbits have already only been vaccinated with the existing Nobivac Myxo-RHD vaccine it is recommended that vets vaccinate the rabbit with an inactivated RHD-2 vaccine, such as Filavac or Eravac vaccine, as soon as possible. For boosters due later this year and all subsequent boosters, use Nobivac Myxo-RHD PLUS."
The launch of the vaccine is being supported by a range of educational materials designed to help vets switch and encourage new rabbit owners into the practice. A new website is also in the pipeline, with rabbit owner support videos, an educational launch webinar, a detailer, practice posters, noticeboard materials and e-mail templates as vaccination reminders for rabbit owners.
For further information contact your MSD Animal Health account manager or visit www.nobivacmyxorhdplus.co.uk.
Designed to help veterinary practices save clients' time and improve compliance, VetsDeliver supplies Bravecto - the company's 12 week flea and tick treatment - with the wormer of the vet's choice, by post.
Before the pandemic, practices registered clients for the service online or during an appointment and clients would have to collect the first treatments from the practice.
In response to the pandemic, however, MSD has made now it possible for clients to register from home and get their first treatments sent by post.
Amanda Melvin, Marketing Manager for Companion Animals at MSD Animal Health said: "We are all in unchartered territory and we appreciate the pressure veterinary teams are under to continue to care for their clients and local pet community.
"Many businesses are having to add new services to support online facilities and home delivery, and for vets there is also now a need to reduce footfall into practice while still generating income. Making sure effective parasite control is available will help improve compliance as temperatures rise and the risks to the health of our pets increase. It's one less thing for you and your clients to worry about."
For further information, contact your MSD Animal Health account manager or go to www.msd-animal-health-hub.co.uk/vetsdeliver.
The first webinar will be run by Dr Sarah Caney (pictured right), the CEO and founder of Vet Professionals, and Dr Hannah Newbury, technical lead vet at MSD Animal Health.
It will cover how telemedicine can benefit you, your practice and your patients. Sarah and Hannah will offer practical tips on how to set up a remote consultation, what you can do via telemedicine during the UK lockdown, and how to carry out these consultations and provide care during this time. There will also be an opportunity to ask specific questions in advance.
The series will also explain the financial benefits of remote consulting and the release of a new telemedicine platform.
To register for the first webinar, visit: https://attendee.gotowebinar.com/register/4735768510902351372.
Click here to submit your questions before the webinar: https://getfeedback.com/r/hBY8qihT/q/1.
Apparently, there were over 100 times more recorded outbreaks of equine flu across the UK in 2019 than the year before1, and numerous equestrian events were cancelled as a result.
The company says that despite this, as of 2019, only about half of all UK horses are vaccinated2.
Blaise Scott-Morris MRCVS, Equine Marketing and Technical Manager at MSD Animal Health said: "Last year’s outbreaks of equine flu rocked the equine world, raising important animal welfare issues and costing the racing industry millions.
"Furthermore, they highlighted the need for good preventative healthcare and, in particular, vaccination. It’s vital that more owners are encouraged to vaccinate and those that already have, to keep up with their annual vaccinations and health checks so we don’t experience the same suffering again."
MSD's campaign invites horse owners to join the movement to #fightequineflu, and there is a range of materials to help practices promote the campaign and encourage clients to talk about vaccination and preventative healthcare, including an educational infographic poster, a social media pack and new resources on the Chameleon appointment reminder system.
MSD will itself be promoting the campaign on social media (Facebook: @Keeping Britains Horses Healthy, Instagram: @KeepingHorsesHealthy), and through partnerships with consumer channels such as Horse and Country TV.
There is also a new information resource online at www.kbhh.co.uk/achoo, which offers horse owners links to a range of other educational preventative health materials and horse care advice.
To request your Fight Equine Flu practice pack, speak to your MSD account manager.
Through the new service, which is designed to save clients' time and improve compliance, practices can arrange for owners to receive Bravecto for 12 week flea and tick control, together with the wormer of the vet's choice for six months to a year.
To use the new service, practices need to register clients on a portal provided by Easy Direct Debit (EDD) during the appointment. The first prescription is then dispensed at the practice with subsequent prescriptions sent direct to the owner in the post.
Amanda Melvin, Marketing Manager at MSD Animal Health said: "We launched VetsDeliver at the London Vet Show and had an extremely positive response.
"It is designed to build on the trust pet owners already have with their veterinary practices and adds convenient delivery to their door that is now familiar to most consumers. All branding and packaging has been designed to be eye-catching while communicating a high quality, professional service that reflects the quality of the veterinary practice.
"Furthermore, VetsDeliver will be the first service to offer 12-week flea and tick protection and provide the practice with the ability to add its wormer of choice. It’s easy for vets to sign-up clients and by offering Bravecto we reduce the number of deliveries and packaging required compared to monthly treatments."
Amanda added: "Vet practices remain an important source of reminders for owners to apply respective parasite treatment, however, it is mostly owners themselves (65%1) who try to remember the treatment.
"VetsDeliver builds on the advantage of the well-established bond between veterinary practices and owners to improve the reminding system. The service will ensure these reminders coincide with the delivery of the product so veterinary practices play an even bigger role in aligning the service to the personal needs of owners."
For further information contact your MSD Animal Health account manager or visit: www.msd-animal-health-hub.co.uk/vetsdeliver .
The website has been redesigned to help pet owners improve their understanding of the disease and support their commitment to treating their pet, thus improving the survival rates of diabetic pets.
The site includes videos which show how to give insulin injections to dogs and cats. There are also links to the Pet Diabetes Tracker App, which helps owners of diabetic pets monitor and record their pets’ progress. There are also tools to help pet owners build glucose curves they can share with their veterinary practice, and FAQs that will answer their main concerns.
The company is also offering additional support to help veterinary practices raise awareness of pet diabetes in the form of staff training and a Pet Diabetes Month Resource Pack.
Caroline Darouj, Senior Product Manager at MSD Animal Health said: "Pet diabetes continues to rise in the UK1,2 due to the growing prevalance of obesity in our pets. Research has shown that up to 20% of diabetic pets die, or are euthanised, within a year of diagnosis3. Many of these early deaths however, are avoidable and effective management can result in good outcomes in most pets. A diabetes diagnosis should not be a life sentence for our pets.
"This campaign and new website will make a big difference, giving practices the tools to engage pet owners, provide treatments plans and explain effective disease management. Diabetes is a disease with many elements that can feel overwhelming for pet owners so it’s vital that all veterinary practice team members have the right resources to be able to advise and support them so their pets can lead long and happy lives."
To sign up for a pack practices should go to www.msd-animal-health-hub.co.uk/PDM
MSD's push is being driven by the rising number of cases of Leishmaniasis cases in the UK, including the first report earlier this year of dog-to-dog transmission of the disease.
Caroline Darouj, Product Manager at MSD Animal Health said: "Whilst accurate statistics on the number of cases seen in UK practices are not available, the VMD has reported an annual increase in the number of leishmaniasis treatments imported since records started in 2006.
"Based on applications for Special Import Certificates for Milteforan and Glucantime, there were 27 times as many cases treated in 2018 (439) compared to 2006 (16)*.
"Leishmaniasis is proving to be a significant threat to travelling dogs, a situation that has been widely reported in the vet press, so LetiFend will offer veterinary practices and dog owners throughout the UK reassurance. A single dose primary course given four weeks before travel makes it ideal for non-regular travelers."
Letifend is indicated to reduce the risk of developing active infection and/or clinical disease after exposure to L. infantum from 28 days post vaccination1,2. It offers protection for 365 days after a single annual dose. The company says it has excellent tolerability shown in a wide range of breeds and ages, and in field trials in areas at high risk of infection had an efficacy rate of 72%4.
LetiFend is a non-adjuvanted vaccine which MSD says ensures a targeted immune response with a high level of safety.
MSD says a dog vaccinated with LetiFend is at 9.8 times less risk of presenting clinical signs, at 3.5 times less risk of presenting parasites, and thus at 5 times less risk of developing clinical leishmaniasis1. It can be applied from six months of age via subcutaneous administration.
For further information contact your MSD Animal Health account manager.
*Information from VMD following a Freedom of Information Act request.
Katie (pictured right) was awarded £1,000 for her research into the use of an ATP bioluminescence meter to monitor cleaning, with the aim of improving hospital hygiene.
The research is part of her study towards her Certificate in Surgical Nursing.
Katie said: "While we don’t have a clinical infection problem at our hospital I believe that there is always a need to improve hygiene standards across the industry as a whole. My aim is to prove that there are easily implementable, and affordable, processes that will improve the hygiene levels of the clinical areas in which I will work. I hope that this can then be rolled out further across the hospital and implemented across our branches and the veterinary industry as a whole."
Michelle Townley, veterinary advisor at MSD Animal Health said: "As the first veterinary nurse to receive one of our research bursaries it’s appropriate that this has been awarded for work that can easily support future developments within the industry. We are committed to preserving and improving the health, well-being and performance of animals so this piece of research fits well with this important goal.
MSD Animal Health launched its first Veterinary Nurse Research Bursary last year, adding to its existing vet surgeon and vet student schemes. One £1000 bursary has been made available to the student or qualified veterinary nurse in the UK with the best research project application. It offers an opportunity to win additional prizes of £1,000 and £500 for the best research projects and presentations at the MSD Animal Health’s Research Bursary Day in June 2020.
For further details go to the MSD Animal Health Research Bursary website at www.msdahresearchbursary.co.uk.
The company points to a study which showed that cats treated Bravecto Plus showed no visible signs of mites at 14 days and 100% efficacy was confirmed at 28 days1. This, says the company, means that Bravecto Plus now gives 12 week control of fleas and ticks, eight week prevention of heartworm disease, treatment of roundworm and hookworm, and treatment of ear mites.
Hannah Newbury, Companion Animal Technical Lead at MSD Animal Health said: "With 1 in 4 cats in the Big Flea Project study having fleas2, we can conclude that pet owner compliance to parasite prevention is currently poor.
"This new licence is an important development for vets and cat owners, offering greater convenience, while helping improve flea and tick compliance. Bravecto Plus builds on the qualities of Bravecto and offers vets and cat owners another tool in the fight against an even broader range of potentially harmful parasites.
"Research by MSD Animal Health shows that 82% of cat owners believe that the ideal flea and tick treatment lasts longer than 2 months3 and vets can offer their cat owners this and more with BRAVECTO PLUS due to its 12 week duration of activity4.
For further information contact your MSD Animal Health Account Manager.
Claire Gotto, Veterinary Advisor at MSD Animal Health said: "With increasing numbers of pets travelling abroad1 and the risk of exposure to exotic diseases, we need to ensure Britain’s pets are protected by providing owners with advice on comprehensive preventative healthcare for their travelling pets.
"This is particularly important as pet travel legislation is primarily in place to protect human health, and pet owners may be unaware of the similar risks to their pets.
"As an industry, we should therefore be advocating preventative healthcare, in addition to the legislation, in order to protect not only individual travelling pets from exotic disease, but also the UK pet population as a whole."
MSD says the risk of exotic disease to travelling pets was highlighted by the results of the Big Tick Project which showed that 76% of dogs travelling abroad returned with ticks2. This included Rhipicephalus sanguineus and Dermacentor reticulatus, the latter of which was found to carry Babesia canis3, a potentially life-threatening pathogen.
The risk to the UK pet population from travelling pets have been highlighted by recent cases of babesiosis4 and leishmaniasis5 in untravelled dogs within the UK.
The Safe Journey campaign includes educational materials about potential exotic disease risks abroad, including Babesiosis, Ehrlichiosis, Rabies, Dirofilariasis (heartworm), Leishmaniasis, Leptospirosis and Echinococcus multilocularis (tapeworm), and the preventive healthcare required to reduce the risk.
Materials available include veterinary practice posters, social media material and leaflets.
It's a subject that will be front of many people's minds following the recent cases of equine flu.
As part of the campaign, MSD has produced a range of veterinary practice support materials to help you engage with owners and yards on the subject of preventative healthcare best practice and compliance.
The range includes shareable social media content, videos, a 'What's Your Risk' practice poster, an online risk assessment tool and a number of downloadable information leaflets. Practices will also be supported through the Keep Britain's Horses Health (KBHH) web page, Facebook page and Twitter.
MSD says there are also planning and evaluation resources to help practices manage an effective campaign.
Vicki Farr, Equine Veterinary Advisor at MSD Animal Health said: "The recent outbreaks of equine flu have rocked the horse-racing world, costing the industry millions and raising important animal welfare issues. Furthermore, they have highlighted the need for good preventative healthcare and, in particular, vaccination.
"HHW will therefore come at a relevant time for horse owners and yards when the impact of equine flu is still at the front of their minds.
"This year HHW will provide vital tools for practices; building on the knowledge and resources we’ve acquired throughout the KBHH campaign and from previous HHWs.
"Our focus is on engaging owners and yards on understanding the risk of disease for their horse, while rewarding them for best practice. We are again providing a wide range of resources for practices to help them create an engaging and successful campaign that helps build knowledge amongst the equine community."
For further information, talk to your MSD Animal Health Equine Account Manager, call 01908 685685 or refer to KBHH social media feeds on Facebook page and Twitter (@keepinghorseshealthy).